Scientists probe genetic switch behind superbug's double defense
NCT ID NCT07469436
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study examines 80 samples of Pseudomonas aeruginosa bacteria that are resistant to multiple antibiotics. Researchers will measure the activity of a gene called mexB, which helps the bacteria pump out drugs, and check how much slime (biofilm) the bacteria produce. The goal is to see if these two defense mechanisms are linked, which could help design better treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could point toward new ways to fight drug-resistant Pseudomonas infections by targeting efflux pumps or biofilms.
What could go wrong
This is a lab study on bacterial samples, not a treatment trial. Findings may not directly lead to new drugs or apply to all infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOMONAS AEROGINOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••